Special Notice / Hearing: None__
Vote Required: Majority
To: Honorable Board of Supervisors
From: Colleen Chawla, Chief, San Mateo County Health
Chester J. Kunnappilly, MD, Chief Executive Officer, San Mateo Medical Center
Subject: Issuance of Purchase Orders to Cepheid for Lab Supplies
RECOMMENDATION:
title
Adopt a resolution authorizing the County Purchasing Agent to issue purchase orders to Cepheid for lab supplies, for the term of December 30, 2025 through December 29, 2026, in an amount not to exceed $400,000.
body
BACKGROUND:
The San Mateo Medical Center (SMMC) laboratory (lab) owns and utilizes Cepheid's GeneXpert system. GeneXpert is an on-demand, real-time polymerase chain reaction (PCR) lab instrument that performs rapid testing and provides testing in a single, self-contained, single-use reagent cartridge. The assay is fully automated, allowing for minimal technologist preparation or hands-on time. SMMC currently uses GeneXpert to perform the Xpert Xpress Multiplex Vaginal Panel (MVP) assay to aid in the diagnosis of bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis in symptomatic women from a single swab within an hour. This assay provides clinicians with precise, accurate results and identifies disease states at a much higher percentage than the traditional methods. Additionally, the MVP specimen has a stability of 42 days versus 30 minutes for the traditional method, allowing all SMMC clinics and County services to collect and have samples analyzed without the issue of time. SMMC also uses GeneXpert to perform the Xpert MRSA NxG, an accurate, fast, on-demand PCR test that detects methicillin-resistant Staphylococcus aureus (MRSA) directly from nasal swabs, allowing for the surveillance of MRSA infections for all admitted patients. SMMC Lab monitors the performance of test GeneXpert assays by completing required quality control and verifications, as well as blind sample testing that is correlated with other...
Click here for full text